Division of Renal, Department of Medicine, Peking University First Hospital, Beijing, China.
Institute of Nephrology, Peking University, Beijing, China.
Am J Nephrol. 2020;51(6):483-492. doi: 10.1159/000507213. Epub 2020 Apr 22.
A revision of the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification for lupus nephritis has been published in 2018. The current study aimed to verify the utility of this system.
A total of 101 lupus nephritis patients from a large Chinese cohort who underwent renal biopsy in Peking University First Hospital were reevaluated by 2 renal pathologists, who had no knowledge of the clinical findings. The association between clinical data at the time of initial renal biopsy and follow-up and pathological features were further analyzed on all patients selected.
The mean age of the cohort was 33 years with a male/female ratio of 1:9, and a median follow-up period of 128 months. The presence and extent of mesangial hypercellularity, endocapillary hypercellularity, global and segmental glomerulosclerosis, neutrophil exudation/karyorrhexis, glomerular hyaline deposits, extracapillary proliferation (crescents), tubular atrophy/interstitial fibrosis, and interstitial inflammation were significantly correlated with several clinical renal injury indices (systemic lupus erythematosus disease activity index, serum creatinine value, proteinuria, and C3 level) at the time of biopsy. By multivariable Cox hazard analysis, fibrous crescents, tubular atrophy/interstitial fibrosis, and the modified National Institutes of Health chronicity index were independent risk factors for patients' composite renal outcomes (hazard ratio [HR] 4.100 [95% CI 1.544-10.890], p = 0.005; HR 8.584 [95% CI 2.509-29.367], p = 0.001; and HR 3.218 [95% CI 1.138-9.099], p = 0.028; respectively).
The 2018 revision of the ISN/RPS classification for lupus nephritis has utility for prediction of clinical renal outcomes.
2018 年发布了国际肾脏病学会/肾脏病理学会(ISN/RPS)狼疮肾炎分类的修订版。本研究旨在验证该系统的实用性。
对来自北京大学第一医院大型中国队列的 101 例狼疮肾炎患者进行了重新评估,由 2 名肾脏病理学家进行评估,他们对临床发现一无所知。对所有入选患者进一步分析了初始肾活检时的临床数据与随访和病理特征之间的关系。
队列的平均年龄为 33 岁,男女比例为 1:9,中位随访时间为 128 个月。系膜细胞增生、内皮下细胞增生、全球和节段性肾小球硬化、中性粒细胞渗出/核碎裂、肾小球透明样沉积、细胞外增殖(新月体)、肾小管萎缩/间质纤维化和间质炎症的存在和程度与几个临床肾损伤指标(系统性红斑狼疮疾病活动指数、血清肌酐值、蛋白尿和 C3 水平)在活检时显著相关。通过多变量 Cox 风险分析,纤维性新月体、肾小管萎缩/间质纤维化和改良的 NIH 慢性指数是患者复合肾脏结局的独立危险因素(风险比[HR]4.100[95%CI1.544-10.890],p=0.005;HR8.584[95%CI2.509-29.367],p=0.001;和 HR3.218[95%CI1.138-9.099],p=0.028;分别)。
2018 年 ISN/RPS 狼疮肾炎分类修订版可用于预测临床肾脏结局。